isoxazoles has been researched along with Giant Cell Arteritis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Diamantopoulos, AP; Hetland, H; Myklebust, G | 1 |
| Adizie, T; Borg, F; Christidis, D; Dasgupta, B; Dharmapaliah, C | 1 |
| Stone, JH; Stone, JR; Unizony, S | 1 |
1 review(s) available for isoxazoles and Giant Cell Arteritis
| Article | Year |
|---|---|
New treatment strategies in large-vessel vasculitis.
Topics: Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Arteritis; Giant Cell Arteritis; Humans; Immunologic Factors; Isoxazoles; Leflunomide; Receptors, Interleukin-6; Rituximab; Takayasu Arteritis | 2013 |
2 other study(ies) available for isoxazoles and Giant Cell Arteritis
| Article | Year |
|---|---|
Leflunomide as a corticosteroid-sparing agent in giant cell arteritis and polymyalgia rheumatica: a case series.
Topics: Adrenal Cortex Hormones; Aged; Female; Giant Cell Arteritis; Giant Cells; Humans; Isoxazoles; Leflunomide; Male; Middle Aged; Polymyalgia Rheumatica | 2013 |
Efficacy and tolerability of leflunomide in difficult-to-treat polymyalgia rheumatica and giant cell arteritis: a case series.
Topics: Aged; Aged, 80 and over; Antirheumatic Agents; Case-Control Studies; Female; Giant Cell Arteritis; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Middle Aged; Polymyalgia Rheumatica; Prospective Studies; Recurrence; Treatment Outcome | 2012 |